NICLOMED
Live / Registered — Registered (as of 09 Apr 2024)
What this means for you
Registered since 09 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97319416
- Registration number
- 7356365
- Mark type
- Stylized text
- Filed
- 18 Mar 2022
- Published for opposition
- 27 Jun 2023
- Registered
- 09 Apr 2024
- Attorney of record
- Ashley D. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Nutritional supplements, namely, probiotic compositions; Anti-arthritic compositions and preparations; Medicaments for inhibiting the growth and metastasis of malignant cells; Medicaments for enhancing resposiveness of malignant cells to chemotherapeutic agents; Medicaments for targeting cancer linked cellular pathways and targeting mTOR, STAT3, and NF-kB and Notch pathways; Medicaments for enhancing apoptosis in cells subjected to glucose deprivation; Medicaments for enhancing ROS-activated and JNK-mediated apoptosis in cells subjected to glucose deprivation
Owner
Prosecution history
- 09 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Feb 2024 — USE AMENDMENT FILED
- 04 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 22 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jun 2023 — PUBLISHED FOR OPPOSITION
- 07 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 May 2023 — ASSIGNED TO EXAMINER
- 15 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED